|
業務類別
|
Biotechnology |
|
業務概覽
|
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function. |
| 公司地址
| 350 Oyster Point Boulevard, South San Francisco, CA, USA, 94080 |
| 電話號碼
| +1 650 624-3000 |
| 傳真號碼
| +1 650 624-3010 |
| 公司網頁
| https://www.cytokinetics.com |
| 員工數量
| 673 |
| Mr. Jeffrey J. Hessekiel |
Executive Vice President, Chief Legal and Administrative Officer |
美元 85.25K |
17/04/2026 |
| Dr. Fady Ibraham Malik, M.D.,PhD |
Executive Vice President, Research and Development |
美元 629.78K |
17/04/2026 |
| Mr. Robert I. Blum |
Director, President and Chief Executive Officer |
美元 853.07K |
17/04/2026 |
| Mr. Sung H. Lee |
Executive Vice President, Chief Financial Officer and Principal Accounting Officer |
美元 572.92K |
17/04/2026 |
| Mr. Andrew M. Callos |
Executive Vice President and Chief Commercial Officer |
美元 581.68K |
17/04/2026 |
|
|
| Dr. Robert A. Harrington, M.D. |
Independent Director |
17/04/2026 |
| Mr. James M. Daly |
Independent Director |
17/04/2026 |
| Dr. John T. Henderson, M.B. |
Chairman of the Board |
17/04/2026 |
| Ms. Nancy J. Wysenski |
Independent Director |
17/04/2026 |
| Dr. Edward M. Kaye, M.D. |
Independent Director |
17/04/2026 |
| Dr. Wendell D. Wierenga,PhD |
Independent Director |
17/04/2026 |
| Mr. Robert I. Blum |
Director, President and Chief Executive Officer |
17/04/2026 |
| Ms. B. Lynne Parshall, Esq.,J.D. |
Independent Director |
17/04/2026 |
| Ms. Muna Bhanji, Ph. |
Independent Director |
17/04/2026 |
| Mr. Robert E. Landry |
Independent Director |
17/04/2026 |
|
|
|
|
